StockGlow

Alligator Bioscience AB (publ) (ATORX.ST)

Develops antibody drugs to fight cancer, currently testing several candidates in clinical trials.

0.04-0.01%Healthcare
Compare ATORX.ST with
StockGlow Score
19
Bearish
BearishBullish
1 year ago-99.3%

The outlook

ATORX.ST is trading near its 52-week low with minimal analyst coverage showing an average price target roughly 6× higher than the current price. The stock sits well below both its 50- and 200-day moving averages, reflecting a weak recent trend. The wide gap between target and current price reflects sparse coverage rather than consensus conviction.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +616% vs current price
Market cap
$26.3M
52-wk high
5.99
52-wk low
0.03
50-day avg
0.17
200-day avg
0.40
Trailing P/E
—

Similar stocks

CANTA.STCantargia AB (publ)$1.89+1.07%ONCO.STOncopeptides AB (publ)$1.61-0.06%BINV.STBioInvent International AB (publ)$23.10-1.07%HNSA.STHansa Biopharma AB (publ)$36.84-0.59%BIOA-B.STBioArctic AB (publ)$324.80+0.68%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy